Evidence map›Paper›PMID 28003092›Full record

ArticleKidney international2017

A rose by any other name: is stage 3a chronic kidney disease really a disease?

Christina M Wyatt

Abstract readComment
PubMed Publisher
In one paragraph

Article in Kidney international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. CKD: A Call for an Age-Adapted Definition.Journal of the American Society of Nephrology : JASN · 2019
    Review
  3. Article
  4. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Christina M WyattDivision of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: christina.wyatt@mssm.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Experts have questioned the clinical relevance of early stage 3 chronic kidney disease, particularly in elderly individuals and in those without albuminuria. A recent study published in PLoS Medicine provides further evidence that many older adults with stage 3a chronic kidney disease will never worsen, whereas some may even improve. Despite limited generalizability, the results support the current, more nuanced classification of chronic kidney disease for use in clinical practice and in future epidemiologic research.

Indexed as

Renal Insufficiency, ChronicAlbuminuriaHumans

Identifiers

PMID28003092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.